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Abstract
Rheumatoid arthritis (RA, MIM 180300) is a chronic and complex autoimmune disease. Using the
North American Rheumatoid Arthritis Consortium (NARAC) data set provided in Genetic
Analysis Workshop 16 (GAW16), we used the genotype-trait distortion (GTD) scores and
proposed analysis procedures to capture the gene-gene interaction effects of multiple susceptibility
gene regions on RA. In this paper, we focused on 27 RA candidate gene regions (531 SNPs) based
on a literature search. Statistical significance was evaluated using 1000 permutations. HLADRB1
was found to have strong marginal association with RA. We identified 14 significant interactions
(p < 0.01), which were aggregated into an association network among 12 selected candidate genes
PADI4, FCGR3, TNFRSF1B, ITGAV, BTLA, SLC22A4, IL3, VEGF, TNF, NFKBIL1, TRAF1-C5, and MIF.
Based on our and other contributors’ findings during the GAW16 conference, we further studied
24 candidate regions with 336 SNPs. We found 23 significant interactions (p-value < 0.01), nine
interactions in addition to our initial findings, and the association network was extended to include
candidate genes HLA-A, HLA-B, HLA-C, CTLA4, and IL6. As we will discuss in this paper, the reported
possible interactions between genes may suggest potential biological activities of RA.

Background
Rheumatoid arthritis (RA) is a common inflammatory
disorder with complex etiology. Although the causes of
RA are still unclear, it is believed to be attributed to both
genetic and environmental factors. During the last few
decades, many new genetic regions have been identified

to associate with RA. Remmers et al. [1] showed that
STAT4 was an important genetic marker for both RA and
systemic lupus erythematosus susceptibility. Kurreeman
et al. [2] applied the candidate gene approach to the
TRAF1-C5 region and found a polymorphism that
increased the susceptibility and severity of RA. Plenge
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et al. [3] studied 14 candidate genes and found
significant associations between RA and PTPN22,
CTLA4, and PADI4. Although many genes have shown
suggestive connections with RA, only HLADRB1 and
PTPN22 have been confirmed to increase the genetic risk
of developing RA [4]. An explanation for the large
number of identified genes might lie in the existence of
gene-gene interactions, which, while helpful in identifying and compiling genes, also made the analysis much
more complicated.
The traditional approaches used in association studies
analyze markers marginally one at a time. As a result,
valuable information on the interactions of genes was
lost. Zheng et al. [5] proposed an association measure,
the genotype-trait distortion (GTD), for evaluating
association information on unphased multilocus genotypes from case-control data. GTD was shown to be able
to capture interactions between markers that were
associated with the disease [5].
Many current association studies are based on dense
single-nucleotide polymorphism (SNP) data, with multiple SNPs corresponding to one gene. SNP-based methods are used to identify and replicate the most significant
SNP. Without considering the dependence and functional relevance among SNPs within the same gene, most
SNP-based association analysis may lead to falsenegative results. As marker density increases, one could
consider a gene-based analysis that offers a number of
advantages, for instance, taking into account possible
multiple disease-associated functional variants within a
gene and overcoming the dependence among SNPs due
to close proximity. In this study, we used the GTD score
and applied a gene-based analysis on two sets of RA
candidate genes from the North American Rheumatoid
Arthritis Consortium (NARAC) data as part of Problem 1
of the Genetic Analysis Workshop 16 (GAW16).

Methods
Gene Set I
The Illumina data set of GAW16 Problem 1 consists of
545,080 SNPs genotyped on 868 RA cases and 1194
unaffected controls from NARAC. In our study, 531 SNPs
from 27 candidate gene regions were considered
(Table 1). The SNPs numbers and locations were
identified by using the SNP mapping information from
the National Cancer Institute’s Cancer Genetic Markers
of Susceptibility (CGEMS) initiative [6]. We included all
related SNPs within each gene in the analysis. These 27
candidate genes were selected based on our search of the
RA literatures. Among these 27 candidate genes,
HLADRB1 and PTPN22 have been widely studied and
confirmed to be associated with RA risk. Some of the
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candidate genes (PADI4, FCRL3, FCGR3, TNFRSF1B,
STAT4, CTLA4, IL4, HAVCR1, TNF, MICA, NFKBIL1,
OLIG3-TNFAIP3, TRAF1-C5, MHC2TA, and MIF) have
been replicated in different populations. A few candidate
genes (IL10, BTLA, IL1B, ITGAV, SLC22A4, IL3, VEGF,
and RUNX1) showed positive association in individual
studies but have not been replicated in other independent data sets. In addition, we also included DLG5 and
CARD15 because they were found to be associated with
several autoimmune diseases. SNPs with missing data
were imputed by fastPhase [7].
Gene Set II
After the gene × gene interaction group discussion during
the GAW16 conference, 24 candidate genes were selected
for further analysis based on the contributors’ findings
(Table 1), 17 of which were considered in our original
analysis (Gene Set I). The seven added genes are IL13,
HLA-A, HLA-B, HLA-C, LTA, IL6, and MS4A1, which were
identified in other contributors’ studies. In other words,
we applied our method to re-analyze the same RA data
with different candidate genes from Gene Set I.

Methods
Given k SNP makers, there are 3k possible unphased
genotypes. We can use the following GTD statistic
defined on the sum of squared difference between
genotypes’ relative frequency among the cases and
controls to measure the joint effects of these k SNPs on
the disease status, i.e.,
3k

v=

∑
s =1

2

⎛ n D, s nU , s ⎞
−
⎜
⎟ .
nU ⎠
⎝ nD

(1)

The statistic ν and its variations have been applied
successfully in a number of studies [5,8-10]. Specifically,
GTD was applied to a candidate gene study of RA during
GAW15 [10] and identified significant higher-order
interactions that were missed by other methods such as
the multifactor dimensionality reduction (MDR)
[10-12].
To identify significant interactions, we applied 1000
permutations of the case-control outcomes as in Lo et al.
[13]. Based on ν, we applied the following gene-based
analysis procedures developed by Lo et al. [13] to
analyze our data sets:
1. Suppose that there are l genes with mli SNPs in
gene i and the total number of SNPs is m ( ∑ m i = m ).
For example, l = 27 and m = 531 in Genei =1Set I. We
calculated v i d for SNP d of gene i (k = 1) and took an
average over the mi SNPs for each gene i, which resulted
in l averages of the marginal effect of each gene.
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Table 1: RA candidate genes

Gene

Gene Set I

Gene Set II

Locus

SNPs

PTPN22
PADI4
FCRL3
FCGR3
IL10
TNFRSF1B
IL1B
ITGAV
STAT4
CTLA4
BTLA
SLC22A4
IL13
IL3
IL4
HAVCR1
VEGF
HLADRB1
MICA
HLA-A
HLA-B
HLA-C
LTA
NFKBIL1
TNF
OLIG3 - TNFAIP3
IL6
TRAF1-C5
DLG5
MS4A1
MHC2TA
CARD15
RUNX1
MIF

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes
Yes
No
No
No
No
Yes
Yes
Yes
No
Yes
Yes
No
Yes
Yes
Yes
Yes

Yes
Yes
No
Yes
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
No
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
No
Yes
No
No
No
Yes

1p13
1p36.13
1q21.2-q22
1q23
1q31-q32
1p36.3-p36.2
2q14
2q31
2q32.2-q32.3
2q33
3q13.2
5q31
5q31
5q31.1
5q31.1
5q33.2
6p12
6p21.3
6p21.3
6p21.3
6p21.3
6p21.3
6p21.3
6p21.3
6p21.3
6q23
7q21
9q33-q34
10q23
11q31
16p13
16q12
21q22.3
22q11.2

12
18
8
4
16
21
7
16
30
5
6
19
6
3
7
15
12
5
32
6
24
29
11
19
10
76
14
31
17
13
12
11
104
15

2. We randomly permuted the labels of case (Y = 1) and
control (Y = 0) and repeated Step 1 on the permuted data
while the original dependence among SNPs in each gene
were retained.
3. To find the pair-wise interaction among the l genes, we
examined l × (l-1)/2 gene pairs. We first calculated the
interaction genotype statistics v i d j e for m × (m-1)/2 SNP
pairs (k = 2) and defined the SNP-wise interaction as the
ratio of incremental interaction versus the maximum of
the two marginal effects as in Eq. (2) where “∨ “ stands
for maximum of the two values.

r(i d , j e ) =

v id je − v id ∨ v je
v id ∨ v je

(2)

Second, we defined the interaction between genes i and j
as the average of all SNP-wise ratios in Eq. (3). The ratio
is termed as the “mean interaction ratio,” Mean-ratio, or
R statistic. In addition, we also defined the gene-level
“average maximum marginal,” or M, as in Eq. (4).

Rij =

Mij =

mj
m
∑d =i1 ∑e =1 r(i d , j e )

(3)

m im j

mj
m
∑d =i1 ∑e =1 (v i d ∨ v j e )

(4)

m im j

4. Applying the calculation outlined in Step 3 on the
permuted data sets, we obtained a set of l × (l-1)/2 values
{ ( Mij( p) , Rijp ); 1 ≤ i < j ≤ l } for each permutation p. The
Mean-ratio curve method of the following was applied to
identify significant gene-pairs. All 1000 × l × (l-1)/2 points
were put on the (M, R) plane and separated into 100 bins
according to the M values. Each bin had 10 × l × (l-1)/2 points.
For each bin, we identified the 99 percentile of the
R statistics (R*) that fell within this bin. By fitting a
smoothing spline between the mid-values of each bin
(M*) and R*, we constructed the 99% R threshold
curve conditioning on M. We identified gene-pairs
with observed R statistics above the threshold curve as
significant.
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5. In addition to the mean ratio R, we used another
measure of interaction, the Quantile-ratio statistic. The Q
statistic is calculated as the 90th or 95th-quantile of the
SNP-wise ratios formed by the mimj SNP pairs. Significant Qij values were identified by the curve method.
6. An alternative way to evaluate the statistical significance is the Rank method. Similar to Step 4, we have 10 ×
l × (l-1)/2 points in each bin. The values of R in each bin
are ranked from 1 to 10 × l × (l-1)/2. For each gene pair,
the observed R value received such a rank value T, and
the R value from permutation p received a rank value
T(p). The p-value of the gene-pair is then the proportion
of T(p) ≥ T. In this study a significance level of 0.01 is
used. The same procedure can also be applied to the Q
statistics calculated in Step 5.

Results
From the average maximum marginal statistics, we
observed that all HLADRB1-related gene pairs have the
strongest M values. We applied both Mean-ratio and
Quantile-ratio methods to capture the interactions.
Thirteen interactions are significant at (p < 0.01) by the
Rank method. Seven interactions were identified by the
quantile method at 90th and 95th level. One interaction
(ITGAV and VEGF) was identified by the 90th-Quantile
Rank method. The Curve method identified 10 interactions, all of which were overlapping with that of the Rank
method. Table 2 shows the detailed selection results. In

Figure 1, we reported the 14 significant gene-gene
interactions from Gene Set I (3.51 significant interactions expected by chance) using red lines.
For Gene Set II (2.76 significant interactions expected by
chance), in addition to the interactions identified for
Gene Set I (Table 2), another seven interactions were
found to be significant by the Mean-ratio Rank method
and two additional interactions were found significant
by the Curve method. Figure 1 displays the extended
networks with these interactions. As seen in Figure 1,
MIF seems to be a “hub” in the association network with
nine significant interactions. In addition, IL3, VEGF, and
HLA-B also have at least five significant interactions.
Morand et al. [14] suggested that MIF is a pivotal
mediator of RA. In addition, it has been implicated in
many roles such as leukocyte recruitment, activation,
and the production of pro-inflammatory cytokines. All
of the roles contributed to the pathology of RA and
showed the importance of MIF. Many interactions
identified in our study have been previously discussed
in the literature. It has been demonstrated that serum
and synovial fluid levels of MIF were well correlated
with the VEGF levels in patients with RA [15].
Nakahara et al. [16] indicated that IL-6 blockade
directly suppressed VEGF production in synovial
fibroblasts and may consequently reduce serum VEGF
levels in patients with RA. Kiriakidis et al. [17] also
showed that VEGF production in human macrophages

Table 2: Selected interactions by different proposed procedures (p-value < 0.01)

Curve method
Mean Ratio
IL3 BTLA
IL3 MIF
IL3 PADI4
IL3 SLC22A4
IL3 TNFRSF1B
IL3 TRAF1-C5
MIF BTLA
MIF FCGR3A
MIF ITGAV
MIF TRAF1-C5
MIF CTLA4a

a

Rank method
90% Quantile
IL3 BTLA
IL3 MIF
IL3 PADI4
IL3 TRAF1-C5
MIF BTLA
MIF FCGR3A
MIF TRAF1-C5
FCGR3A
TRAF1-C5a

95% Quantile
IL3 BTLA
IL3 MIF
IL3 PADI4
IL3 TRAF1-C5
MIF BTLA

Mean Ratio
IL3 BTLA
IL3 MIF
IL3 PADI4
IL3 SLC22A4
IL3 TNFRSF1B
IL3 TRAF1-C5
MIF BTLA
MIF FCGR3A
MIF HLA-Ba
MIF ITGAV
MIF TNFRSF1Ba
MIF TRAF1-C5
MIF VEGF
NFKBIL1 HLA-Ba
NFKBIL1 VEGF
NFKBIL1 TNF
VEGF IL6a
VEGF HLA-Ba
HLA-A HLA-Ba
HLA-B HLA-Ca

90% Quantile
a

IL3 MIF
IL3 PADI4
IL3 TRAF1-C5a
ITGAV VEGF
MIF BTLAa
MIF FCGR3Aa
MIF TRAF1-C5a

95% Quantile
IL3 BTLA
IL3 MIF
IL3 PADI4
MIF BTLA
MIF FCGR3A
MIF TRAF1-C5

Significant interactions only identified in Gene Set II.
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Figure 1
Association network with significant interactions identified. All significant interactions identified for Gene Set II are
plotted. Interactions in red were also identified in Gene Set I. Different line widths indicate interactions identified by different
numbers of proposed procedures.

was NF-B-dependent, which agreed with our finding
of interaction between VEGF and NFKBIL1. VEGF may
be directly involved in the activation of RA monocytes
and synoviocytes, producing TNF and IL-6 via a
receptor-coupling event [18]. As noted in Yoo et al.
[18], this may imply a direct interaction between VEGF
and IL-6 or an indirect interaction between VEGF and
TNF via NFKBIL1, also found in our results. Onodera
et al. [19] demonstrated that MIF enhanced NFKB
binding activities of the nuclear extracts from RA
synovial fibroblasts. The NFKBIL1, a divergent member
of I--B proteins that is an inhibitor for NFKB
complex, may have potential interaction between MIF
and NFKBIL1. In Figure 1, we showed that the indirect
connection between MIF and NFKBIL1 via VEGF.
Furthermore, the relation between TNF and NFKBdependent signaling pathway of RA patients was
discussed by Youn et al. [20].

were previously reported in the literature. The association network constructed in our paper may offer
additional evidence and insight on gene-gene interactions in the development of RA. Additional experiments
and independent data are required to confirm our
findings.
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